Navigation Links
DaTSCAN™ (Ioflupane I 123 Injection) Recommended in Updated European Guidelines for Diagnosis of Alzheimer's Disease
Date:10/14/2010

PRINCETON, N.J., Oct. 14 /PRNewswire/ -- GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced that DaTSCAN™ (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.(1)

Specifically, the guidelines, which were last issued in 2007(2), note that SPECT "may increase diagnostic confidence in the evaluation of dementia," adding that dopaminergic SPECT imaging with DaTSCAN is useful in differentiating AD from dementia with Lewy bodies (DLB)(1), a neurological condition that is similar to AD in that it results from the death of nerve cells in the brain.(3) The EFNS recommendation carries a level A grade of evidence – the strongest grade assigned in the guidelines – noting that DaTSCAN can differentiate AD from DLB with sensitivity and specificity of "around 85%."(1,2)

"As the global population ages and the prevalence of dementia rises, it will become increasingly important to be able to differentiate Alzheimer's disease from other types of dementia," said Adrian Holden, EU Head of Medical Professional Services for GE Healthcare. "Neurologists will therefore become increasingly reliant on imaging technologies that can accurately yield a definitive diagnosis. We are pleased that the EFNS has recognized the value of DaTSCAN in facilitating diagnosis of dementia, particularly with regard to distinguishing Alzheimer's disease from dementia with Lewy bodies. We hope the EFNS recommendation results in enhanced provision of timely and appropriate treatment to patients living with dementia – not only
'/>"/>

SOURCE GE Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension
2. US WorldMeds Announces the Launch of Revonto™ (dantrolene sodium for injection)
3. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year
4. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at 52 Weeks
5. The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes
6. Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment
7. FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)
8. Study Showed Lillys GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients
9. Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML)
10. New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data
11. Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... Inc. (Nasdaq: ECTE ) ("Echo"), a medical ... non-invasive, wireless continuous glucose monitoring system, today announced that ... CEO of Echo Therapeutics, will present at "TEN", Noble ... Mr. Doman will make a corporate presentation to ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
(Date:7/9/2014)... findings from Fox Chase Cancer Center paint a relatively ... of breast cancers that have spread to the chest ... that grow into the skin, regardless of size and ... as stage III and called "locally advanced" tumors, ... cancer, often with poor survival. Locally advanced breast cancers ...
(Date:7/9/2014)... used in policing injection drug users in Russia ... , A study, conducted by researchers from ... in collaboration with St. Petersburg Pavlov State University, ... on the health outcomes of a cohort of ... , Those who were arrested by police were ...
(Date:7/9/2014)... N.Y. Although feelings are personal and subjective, ... code that objectively represents emotions across different senses, ... by Cornell University neuroscientist Adam Anderson. , "We ... the orbitofrontal cortex, an area of the brain ... code which captures an individual,s subjective feeling," says ...
(Date:7/9/2014)... There has been a sharp increase in the number ... MyChart, the online, interactive service that allows patients to ... providers, schedule appointments, and renew prescriptions. , Over a ... MyChart each year increased five-fold, while the number ... according to a study by Dr. David Gerber ...
(Date:7/9/2014)... world have been linked to an emerging fungal ... National Institute for Mathematical and Biological Synthesis (NIMBioS) ... , In a series of mathematical models, ... of internal organs in frogs, could cause extinction ... are exposed to the virus every few years, ...
Breaking Medicine News(10 mins):Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 3Health News:BU researchers relate arrests with HIV risk environment 2Health News:Study cracks how the brain processes emotions 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2
... ... appear to continue to resist calling for routine brain monitoring to avoid over medication, especially ... preclude ASA advocating greater patient safety. , ... Newport Beach (PRWEB) February 2, 2010 -- The NFL is giving $1 million ...
... Feb. 1 The Long Beach Library Foundation announces the 9th ... Soloist – A Lost Dream, An Unlikely Friendship, and the Redemptive ... for all ages, are scheduled throughout Long Beach from ... OPENING PUBLIC EVENT - An Evening With Steve Lopez – will take ...
... According ... most common negative patterns in a relationship. Angry individuals may be aware of their problem, ... , ... 1, 2010 -- Personal Power Path announces the launch of an anger management app for ...
... 1 President Obama,s budget, transmitted to Congress this ... Initiative.  Based on projections to continue supporting robust U.S. programs ... -- $16.4 billion is required in FY2011.   ... has an opportunity and must work to get the Obama ...
... , , , DES MOINES, ... lawsuit filed by the Connecticut attorney general, it is ... they need to ensure that they are HIPAA compliant. It is ... the small and medium health care providers, ranging from the local ...
... New research from the University of Pennsylvania School ... resolution by helping them quit smoking. Extended use of a ... recommended by manufacturers boosts the number of smokers who ... backslide into the habit while wearing the patch, according to ...
Cached Medicine News:Health News:Brain Damage: NFL ‘Gets It,' American Society of Anesthesiologists Still Appears ‘Asleep' 2Health News:Brain Damage: NFL ‘Gets It,' American Society of Anesthesiologists Still Appears ‘Asleep' 3Health News:Long Beach Reads One Book 'The Soloist' by Steve Lopez 2Health News:President's Budget for Global Health Far Short of What's Needed - Congress Must Fix 2Health News:President's Budget for Global Health Far Short of What's Needed - Congress Must Fix 3Health News:President's Budget for Global Health Far Short of What's Needed - Congress Must Fix 4Health News:Palisade Systems Comments on the HITECH Lawsuit Filed by the Connecticut Attorney General 2Health News:More smokers kick the habit with extended nicotine patch therapy, Penn research shows 2Health News:More smokers kick the habit with extended nicotine patch therapy, Penn research shows 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: